Literature DB >> 17079409

Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement.

William A Jiranek1, Arlen D Hanssen, A Seth Greenwald.   

Abstract

Use of antibiotic-loaded bone cement for prophylaxis against infection is not indicated for patients not at high risk for infection who are undergoing routine primary or revision joint replacement with cement. The mechanical and elution properties of commercially available premixed antibiotic-loaded bone-cement products are superior to those of hand-mixed preparations. Use of commercially available antibiotic-loaded bone-cement products has been cleared by the United States Food and Drug Administration only for use in the second stage of a two-stage total joint revision following removal of the original prosthesis and elimination of active periprosthetic infection. Use of antibiotic-loaded bone cement for prophylaxis against infection in the second stage of a two-stage total joint revision involves low doses of antibiotics. Active infection cannot be treated with commercially available antibiotic-loaded bone cement as such treatment requires higher doses of antibiotics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079409     DOI: 10.2106/JBJS.E.01126

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  84 in total

1.  In vitro activities of daptomycin-, vancomycin-, and teicoplanin-loaded polymethylmethacrylate against methicillin-susceptible, methicillin-resistant, and vancomycin-intermediate strains of Staphylococcus aureus.

Authors:  Yuhan Chang; Wen-Chien Chen; Pang-Hsin Hsieh; Dave W Chen; Mel S Lee; Hsin-Nung Shih; Steve W N Ueng
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Does dual antibiotic prophylaxis better prevent surgical site infections in total joint arthroplasty?

Authors:  Amy Sewick; Amun Makani; Chia Wu; Judith O'Donnell; Keith D Baldwin; Gwo-Chin Lee
Journal:  Clin Orthop Relat Res       Date:  2012-10       Impact factor: 4.176

3.  Strength of antimicrobial bone cement decreases with increased poragen fraction.

Authors:  Matt Nugent; Alex McLaren; Brent Vernon; Ryan McLemore
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

4.  The results of two-stage revision TKA using Ceftazidime-Vancomycin-impregnated cement articulating spacers in Tsukayama Type II periprosthetic joint infections.

Authors:  Michael Drexler; Tim Dwyer; Paul R T Kuzyk; Yona Kosashvilli; Mansour Abolghasemian; Gilad J Regev; Assaf Kadar; Tal Frenkel Rutenberg; David Backstein
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-08-14       Impact factor: 4.342

5.  [Evidence and consensus based Austrian guidelines for management of acute and chronic nonspecific backache].

Authors: 
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

6.  Does adding antibiotics to cement reduce the need for early revision in total knee arthroplasty?

Authors:  Eric Bohm; Naisu Zhu; Jing Gu; Nicole de Guia; Cassandra Linton; Tammy Anderson; David Paton; Michael Dunbar
Journal:  Clin Orthop Relat Res       Date:  2014-01       Impact factor: 4.176

7.  Chitosan sponges to locally deliver amikacin and vancomycin: a pilot in vitro evaluation.

Authors:  Scott P Noel; Harry S Courtney; Joel D Bumgardner; Warren O Haggard
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

8.  Econazole-releasing porous space maintainers for fungal periprosthetic joint infection.

Authors:  Alexander M Tatara; Allison J Rozich; Panayiotis D Kontoyiannis; Emma Watson; Nathaniel D Albert; George N Bennett; Antonios G Mikos
Journal:  J Mater Sci Mater Med       Date:  2018-05-11       Impact factor: 3.896

9.  Polymethylmethacrylate bone cements and additives: A review of the literature.

Authors:  Manit Arora; Edward Ks Chan; Sunil Gupta; Ashish D Diwan
Journal:  World J Orthop       Date:  2013-04-18

10.  The effect of vancomycin addition to the compression strength of antibiotic-loaded bone cements.

Authors:  Anastasios Lilikakis; Michael P F Sutcliffe
Journal:  Int Orthop       Date:  2008-02-19       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.